— Prostate Circulating Tumor Cells Isolated with TellDx Technology Demonstrates Epigenetic Changes that Silence Immune…
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — For the fifth consecutive year, Verizon Business…
Washington, D.C., Jul 6, 2023 – (ACN Newswire) – Government Blockchain Association (GBA) announced the…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns a rating of BBB to Blue Owl Technology Income Corporation’s (“OTIC”…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of notes issued by DT Auto…
Collaboration expands Carrick’s clinical-stage Oncology program DUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE)…
Collaboration expands Carrick’s clinical-stage Oncology program DUBLIN, Ireland and BOSTON, July 06, 2023 (GLOBE NEWSWIRE)…
SALT LAKE CITY, July 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
SALT LAKE CITY, July 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the…
Anti-HER2 and Anti-HER3 monoclonal antibodies designed to have a high drug-to-antibody ratio intended enhance the…
FREMONT, CA, July 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
FREMONT, CA, July 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS”…
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS”…
6 July 2023 Biodexa Ltd(“Biodexa” or the “Company”) Publication of Manuscript from the PNOC015 (a.k.a….
6 July 2023 Biodexa Ltd(“Biodexa” or the “Company”) Publication of Manuscript from the PNOC015 (a.k.a….
HAMPTON, N.J., July 06, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
HAMPTON, N.J., July 06, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Management team to speak at 2nd In Vivo Engineering of Therapeutic Cells Summit and 8th…